Glucose Teva (Glucose, Anhydrous)

Glucose Teva is used primarily as an excipient in parenteral formulations where a sterile source of carbohydrate is required.

• Provides an immediate source of glucose for cellular metabolism during procedures.
• Serves as an osmotic agent to maintain fluid balance in epidural or intracoronary infusions.
• Acts as a diluent or carrier for other injectable medications.
• Facilitates the preparation of isotonic solutions for intrabursal injections.
• Supports energy requirements in cardiac catheterization procedures.

Adverse reactions to Glucose Teva are generally related to the systemic effects of glucose when administered intravenously or via other parenteral routes.

Common

• Transient hyperglycemia.
• Nausea or vomiting.
• Local irritation at the injection site.
• Headache.
• Flushing or warmth sensation.
• Mild dizziness.

Serious

• Severe hyperglycemia requiring medical intervention.
• Anaphylactic or severe allergic reaction.
• Electrolyte disturbances (e.g., hyponatremia).
• Pulmonary edema in susceptible patients.
• Seizures secondary to extreme glucose shifts.
• Hypoglycemia if glucose is over‑corrected in diabetic patients.

When using Glucose Teva, clinicians should consider patient‑specific factors and monitor for potential complications.

• Assess baseline blood glucose and adjust dosing in diabetic or hypoglycemic patients.
• Use caution in patients with renal or hepatic impairment due to altered glucose metabolism.
• Monitor electrolytes, especially sodium and potassium, during large volume administrations.
• Avoid rapid infusion rates that may cause fluid overload or osmotic shifts.
• Ensure sterile technique to prevent contamination of the product.
• Review patient allergy history before administration.

Glucose Teva may interact with other agents that affect blood glucose levels or fluid balance.

Avoid

• Concurrent high‑dose insulin therapy without glucose monitoring.
• Co‑administration with other hyperosmolar solutions that could exacerbate fluid shifts.
• Use with medications that cause severe hypoglycemia (e.g., sulfonylureas) without close monitoring.

Use with caution

• Beta‑blockers, which may mask hypoglycemia symptoms.
• Diuretics that alter electrolyte status.
• Corticosteroids, which can increase glucose production.
• Cardiac glycosides, where fluid overload may affect cardiac function.